FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to a molecule binding dipeptidyl peptidase-3 (hereinafter – DPP3). The specified DPP3-binding molecule shows affinity with DPP3 in such a way that affinity constant is at least 10-7 M-1, while the specified DPP3-binding molecule blocks DPP3 bioactivity by at least 10%.
EFFECT: invention is effective for the prevention or treatment of diseases or acute conditions in a patient, while the specified disease or acute condition is related to oxidative stress.
11 cl, 6 dwg, 7 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC GUIDANCE AND/OR MONITORING THERAPY FOR TREATING SHOCK | 2020 |
|
RU2835616C1 |
| ILT7 BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2756109C2 |
| SPECIFIC BINDING MOLECULES | 2020 |
|
RU2825837C2 |
| ADAM9-BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2783619C2 |
| VARIANT CD3 BINDING DOMAINS AND THEIR USE IN COMBINATION THERAPY FOR TREATMENT OF DISEASES | 2019 |
|
RU2810222C2 |
| MOLECULES BINDING TO 4-1BB | 2011 |
|
RU2551963C2 |
| METHODS FOR USING CD32B x CD79B-BINDING MOLECULES IN TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS | 2017 |
|
RU2772434C2 |
| ADAMTS-BINDING IMMUNOGLOBULINS | 2018 |
|
RU2781182C2 |
| PD-L1 ANTIBODIES BINDING DOG PD-L1 | 2015 |
|
RU2722562C2 |
| PD-L1 ANTIBODIES BINDING CANINE PD-L1 | 2015 |
|
RU2832918C2 |
